Oneness Biotech Valuation
| 4743 Stock | TWD 73.60 2.60 3.41% |
At this time, the company appears to be overvalued. Oneness Biotech holds a recent Real Value of NT$66.61 per share. The prevailing price of the company is NT$73.6. Our model determines the value of Oneness Biotech from analyzing the company fundamentals such as Return On Equity of 0.0788, operating margin of (0.16) %, and Shares Owned By Insiders of 30.64 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Oneness Biotech's price fluctuation is very steady at this time. Calculation of the real value of Oneness Biotech is based on 3 months time horizon. Increasing Oneness Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Oneness stock is determined by what a typical buyer is willing to pay for full or partial control of Oneness Biotech Co. Since Oneness Biotech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Oneness Stock. However, Oneness Biotech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 73.6 | Real 66.61 | Hype 73.6 | Naive 75.19 |
The intrinsic value of Oneness Biotech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Oneness Biotech's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Oneness Biotech Co helps investors to forecast how Oneness stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Oneness Biotech more accurately as focusing exclusively on Oneness Biotech's fundamentals will not take into account other important factors: Oneness Biotech Total Value Analysis
Oneness Biotech Co is presently anticipated to have takeover price of 92.26 B with market capitalization of 105.11 B, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Oneness Biotech fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
92.26 B | 105.11 B |
Oneness Biotech Investor Information
About 31.0% of the company shares are owned by insiders or employees . The company last dividend was issued on the 24th of August 9022. Oneness Biotech had 1000:1049 split on the 26th of July 2024. Oneness Biotech Co is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Oneness Biotech Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Oneness indicates not a very effective usage of assets in March.Oneness Biotech Ownership Allocation
Oneness Biotech owns a total of 387.86 Million outstanding shares. Oneness Biotech has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Oneness Biotech Profitability Analysis
The company reported the revenue of 65.77 M. Net Loss for the year was (403.3 M) with profit before overhead, payroll, taxes, and interest of 45.04 M.About Oneness Biotech Valuation
Our relative valuation model uses a comparative analysis of Oneness Biotech. We calculate exposure to Oneness Biotech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Oneness Biotech's related companies.8 Steps to conduct Oneness Biotech's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Oneness Biotech's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Oneness Biotech's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Oneness Biotech's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Oneness Biotech's revenue streams: Identify Oneness Biotech's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Oneness Biotech's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Oneness Biotech's growth potential: Evaluate Oneness Biotech's management, business model, and growth potential.
- Determine Oneness Biotech's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Oneness Biotech's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Oneness Stock Analysis
When running Oneness Biotech's price analysis, check to measure Oneness Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oneness Biotech is operating at the current time. Most of Oneness Biotech's value examination focuses on studying past and present price action to predict the probability of Oneness Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oneness Biotech's price. Additionally, you may evaluate how the addition of Oneness Biotech to your portfolios can decrease your overall portfolio volatility.